CEACAM6, a key member of the immunoglobulin superfamily and a nonspecific cross-antigen, may play a synergistic role with various proteins such as ITGB1 and CYR62 in promoting tumor growth, proliferation, migration, and angiogenesis, contributing to CRC occurrence and development (31–33). This evidence concerns the gene ITGB1 and neoplasm.